DK1691804T3 - Nitrooxydderivater af carvedilol og andre beta-blokkere som antihypertensive lægemidler - Google Patents
Nitrooxydderivater af carvedilol og andre beta-blokkere som antihypertensive lægemidlerInfo
- Publication number
- DK1691804T3 DK1691804T3 DK04803434T DK04803434T DK1691804T3 DK 1691804 T3 DK1691804 T3 DK 1691804T3 DK 04803434 T DK04803434 T DK 04803434T DK 04803434 T DK04803434 T DK 04803434T DK 1691804 T3 DK1691804 T3 DK 1691804T3
- Authority
- DK
- Denmark
- Prior art keywords
- carvedilol
- blockers
- beta
- nitric oxide
- oxide derivatives
- Prior art date
Links
- MWUXSHHQAYIFBG-UHFFFAOYSA-N Nitric oxide Chemical class O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 title 1
- 239000002220 antihypertensive agent Substances 0.000 title 1
- 229940127088 antihypertensive drug Drugs 0.000 title 1
- 239000002876 beta blocker Substances 0.000 title 1
- 229940097320 beta blocking agent Drugs 0.000 title 1
- 229960004195 carvedilol Drugs 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C219/00—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton
- C07C219/02—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C219/04—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C219/14—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having at least one of the hydroxy groups esterified by a carboxylic acid having the esterifying carboxyl group bound to a carbon atom of a six-membered aromatic ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C219/00—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton
- C07C219/02—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C219/04—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C219/06—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having the hydroxy groups esterified by carboxylic acids having the esterifying carboxyl groups bound to hydrogen atoms or to acyclic carbon atoms of an acyclic saturated carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/30—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by doubly-bound oxygen atoms
- C07C233/33—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by doubly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C235/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C235/08—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atom of at least one of the carboxamide groups bound to an acyclic carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/42—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/01—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
- C07C311/02—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
- C07C311/08—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/56—Ring systems containing three or more rings
- C07D209/80—[b, c]- or [b, d]-condensed
- C07D209/82—Carbazoles; Hydrogenated carbazoles
- C07D209/88—Carbazoles; Hydrogenated carbazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
- C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/04—One of the condensed rings being a six-membered aromatic ring
- C07C2602/10—One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Ophthalmology & Optometry (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Indole Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP03104484 | 2003-12-02 | ||
| PCT/EP2004/013683 WO2005053685A1 (en) | 2003-12-02 | 2004-12-01 | Nitrooxyderivatives of carvedilol and other beta blockers as antihypertensive drugs |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1691804T3 true DK1691804T3 (da) | 2007-07-16 |
Family
ID=34639309
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK04803434T DK1691804T3 (da) | 2003-12-02 | 2004-12-01 | Nitrooxydderivater af carvedilol og andre beta-blokkere som antihypertensive lægemidler |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US7825263B2 (pl) |
| EP (1) | EP1691804B1 (pl) |
| JP (1) | JP2007513114A (pl) |
| KR (1) | KR20060120677A (pl) |
| CN (1) | CN1886132A (pl) |
| AR (1) | AR047732A1 (pl) |
| AT (1) | ATE358478T1 (pl) |
| AU (1) | AU2004294297A1 (pl) |
| BR (1) | BRPI0416584A (pl) |
| CA (1) | CA2548129A1 (pl) |
| DE (1) | DE602004005748T2 (pl) |
| DK (1) | DK1691804T3 (pl) |
| ES (1) | ES2285549T3 (pl) |
| HR (1) | HRP20070283T3 (pl) |
| IL (1) | IL174959A0 (pl) |
| NO (1) | NO20063057L (pl) |
| PL (2) | PL380065A1 (pl) |
| PT (1) | PT1691804E (pl) |
| RU (1) | RU2006119528A (pl) |
| SI (1) | SI1691804T1 (pl) |
| WO (1) | WO2005053685A1 (pl) |
| ZA (1) | ZA200604458B (pl) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE60233140D1 (de) | 2001-05-02 | 2009-09-10 | Nitromed Inc | Nitrosiertes und nitrosyliertes nebivolol und seine metaboliten, zusammensetzungen und anwendungsverfahren |
| WO2007090733A1 (en) * | 2006-02-06 | 2007-08-16 | Nicox S.A. | Nitrooxy derivatives suitable as alpha2 adrenergic receptor agonists |
| WO2007090793A1 (en) * | 2006-02-06 | 2007-08-16 | Nicox S.A. | Nitrooxy-comprising derivatives of apraclonidine and brimodnidine as al pha2 -adrenergic receptor agonists |
| US9782488B2 (en) | 2007-03-12 | 2017-10-10 | Nektar Therapeutics | Oligomer-beta blocker conjugates |
| EP2160192B1 (en) | 2007-05-14 | 2018-03-28 | Covidien LP | Antimicrobial materials and coatings |
| US8062653B2 (en) * | 2009-02-18 | 2011-11-22 | Bezwada Biomedical, Llc | Controlled release of nitric oxide and drugs from functionalized macromers and oligomers |
| EP3589327A4 (en) * | 2017-03-03 | 2022-04-06 | Synovo GmbH | NOVEL ANTI-INFECTION AND ANTI-INFLAMMATORY COMPOUNDS |
| CN115246774A (zh) * | 2021-04-27 | 2022-10-28 | 南昌弘益科技有限公司 | 一类新型双羰基类阿魏酸衍生物 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2805404A1 (de) * | 1978-02-09 | 1979-08-16 | Merck Patent Gmbh | 1-aryloxy-3-nitratoalkylamino-2-propanole und verfahren zu ihrer herstellung |
| DE3443998A1 (de) | 1984-12-01 | 1986-06-05 | Boehringer Mannheim Gmbh, 6800 Mannheim | Amino-propanol-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel sowie zwischenprodukte |
| DE3512627A1 (de) | 1985-04-06 | 1986-10-09 | Boehringer Mannheim Gmbh, 6800 Mannheim | Amino-propanol-derivate, verfahren zu deren herstellung, verwendung derselben und diese enthaltende arzneimittel |
| ES2065291B1 (es) | 1993-07-30 | 1995-10-01 | Prodesfarma Sa | "nitrato esteres de 1-ariloxi-3-alquilamino-2-propanoles, utilizacion y composicion farmaceutica correspondiente" |
| US5932538A (en) * | 1996-02-02 | 1999-08-03 | Nitromed, Inc. | Nitrosated and nitrosylated α-adrenergic receptor antagonist compounds, compositions and their uses |
| IT1295694B1 (it) | 1996-11-14 | 1999-05-27 | Nicox Sa | Nitrossi derivati per la preparazione di medicamenti ad attivita antitrombinica |
| PE20001302A1 (es) * | 1998-11-27 | 2000-11-30 | Hoffmann La Roche | Preparaciones de una combinacion farmaceutica que contiene carvedilol e hidroclorotiazida |
| IT1311923B1 (it) * | 1999-04-13 | 2002-03-20 | Nicox Sa | Composti farmaceutici. |
| IT1311924B1 (it) * | 1999-04-13 | 2002-03-20 | Nicox Sa | Composti farmaceutici. |
| IT1314184B1 (it) * | 1999-08-12 | 2002-12-06 | Nicox Sa | Composizioni farmaceutiche per la terapia di condizioni di stressossidativo |
| US20050009897A1 (en) * | 2001-04-02 | 2005-01-13 | Karen Anderson | Method of treatment |
| JP2004529204A (ja) * | 2001-05-28 | 2004-09-24 | ケムテック、リサーチ、インコーポレーション | 新規なアルカロイド誘導体及びこれを含有する医薬組成物 |
| ITMI20020148A1 (it) * | 2002-01-29 | 2003-07-29 | Nicox Sa | Nuovi corticosteroidi |
-
2004
- 2004-12-01 EP EP04803434A patent/EP1691804B1/en active Active
- 2004-12-01 DE DE602004005748T patent/DE602004005748T2/de active Active
- 2004-12-01 DK DK04803434T patent/DK1691804T3/da active
- 2004-12-01 US US10/577,912 patent/US7825263B2/en not_active Expired - Fee Related
- 2004-12-01 CA CA002548129A patent/CA2548129A1/en not_active Abandoned
- 2004-12-01 PL PL380065A patent/PL380065A1/pl not_active Application Discontinuation
- 2004-12-01 CN CNA200480035459XA patent/CN1886132A/zh active Pending
- 2004-12-01 WO PCT/EP2004/013683 patent/WO2005053685A1/en active Application Filing
- 2004-12-01 RU RU2006119528/04A patent/RU2006119528A/ru not_active Application Discontinuation
- 2004-12-01 ES ES04803434T patent/ES2285549T3/es active Active
- 2004-12-01 PT PT04803434T patent/PT1691804E/pt unknown
- 2004-12-01 JP JP2006541892A patent/JP2007513114A/ja active Pending
- 2004-12-01 AU AU2004294297A patent/AU2004294297A1/en not_active Abandoned
- 2004-12-01 BR BRPI0416584-5A patent/BRPI0416584A/pt not_active IP Right Cessation
- 2004-12-01 AT AT04803434T patent/ATE358478T1/de not_active IP Right Cessation
- 2004-12-01 AR ARP040104485A patent/AR047732A1/es not_active Application Discontinuation
- 2004-12-01 KR KR1020067010491A patent/KR20060120677A/ko not_active Application Discontinuation
- 2004-12-01 SI SI200430328T patent/SI1691804T1/sl unknown
- 2004-12-01 PL PL04803434T patent/PL1691804T3/pl unknown
-
2006
- 2006-03-31 ZA ZA200604458A patent/ZA200604458B/xx unknown
- 2006-04-11 IL IL174959A patent/IL174959A0/en unknown
- 2006-06-30 NO NO20063057A patent/NO20063057L/no not_active Application Discontinuation
-
2007
- 2007-06-27 HR HR20070283T patent/HRP20070283T3/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| RU2006119528A (ru) | 2008-01-10 |
| ZA200604458B (en) | 2007-04-25 |
| IL174959A0 (en) | 2006-08-20 |
| CN1886132A (zh) | 2006-12-27 |
| US20070072854A1 (en) | 2007-03-29 |
| SI1691804T1 (sl) | 2007-10-31 |
| ES2285549T3 (es) | 2007-11-16 |
| DE602004005748T2 (de) | 2007-12-27 |
| EP1691804B1 (en) | 2007-04-04 |
| PL380065A1 (pl) | 2006-12-11 |
| EP1691804A1 (en) | 2006-08-23 |
| PL1691804T3 (pl) | 2007-08-31 |
| AU2004294297A1 (en) | 2005-06-16 |
| US7825263B2 (en) | 2010-11-02 |
| CA2548129A1 (en) | 2005-06-16 |
| ATE358478T1 (de) | 2007-04-15 |
| WO2005053685A1 (en) | 2005-06-16 |
| KR20060120677A (ko) | 2006-11-27 |
| JP2007513114A (ja) | 2007-05-24 |
| NO20063057L (no) | 2006-06-30 |
| HRP20070283T3 (en) | 2007-11-30 |
| PT1691804E (pt) | 2007-07-04 |
| DE602004005748D1 (de) | 2007-05-16 |
| BRPI0416584A (pt) | 2007-01-30 |
| AR047732A1 (es) | 2006-02-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1478339T3 (da) | Farmaceutiske formuleringer af antineoplastiske midler, specielt temozolomid, fremgangsmåder til fremstilling og anvendelse heraf | |
| DK1824566T3 (da) | Orale sammensætninger indeholdende ekstrakter af rosmaring og beslægtede metoder | |
| DK1940364T4 (da) | Kapselformulering af pirfenidon og farmaceutisk acceptable excipienser | |
| DK1537096T3 (da) | Derivater af dioxan-2-alkylcarbamater, fremstilling og terapeutisk anvendelse heraf | |
| DK1438306T3 (da) | Derivater af UK-2A | |
| DK1580216T3 (da) | Derivater med høj molekylvægt af camptotheciner | |
| DK2072051T3 (da) | Kombination af azelastin og mometason | |
| NO20050476L (no) | Kinolinderivater og deres anvendelse som mykobakterielle inhibitorer | |
| DK1564210T5 (da) | 4-Oxoquinolinforbindelser og anvendelse deraf som HIV-integraseinhibitorer | |
| DK1773999T3 (da) | Vaccine til forebyggelse og behandling af HIV-infektion | |
| DK1608407T3 (da) | Dispergébar formulering af et antiinflammatorisk middel | |
| DK1463506T3 (da) | Substituerede quinazolin-derivater som inhibitorer af aurora-kinaser | |
| DK1544199T3 (da) | Nitrogenholdig kondenseret ringforbindelse og anvendelse deraf som HIV-integraseinhibitor | |
| DK1578755T3 (da) | Phosphonooxyguinalinderivater og deres farmaceutiske anvendelse | |
| DK2508521T4 (da) | Dimaleat af en aminocrotonylforbindelse og fremgangsmåde til fremstilling deraf | |
| DK1651644T3 (da) | Substituerede derivater af thiazol-benzoisothiazoldioxid, fremgangsmåde deraf og deres anvendelse | |
| DK1644021T3 (da) | Fremgangsmåder og sammensætninger til behandlingen af gastrointestinale sygdomme | |
| NO20054143D0 (no) | Pyrimidinderivater for forhindringen av HIV-infeksjon | |
| NO20050346D0 (no) | Nitro-oksyderivater av syklooksygenase-2-inhibitorer | |
| IS7552A (is) | Bensótengdar heteróarýl amíð afleiður af þíenópýridíni, gagnlegar sem meðferðarmiðlar, lyfjasamsetningar sem innihalda þær og aðferðir við notkun þeirra | |
| NO20054135D0 (no) | Kipolinon/benzoksazin derivater og anvendelser derav | |
| DK1490037T3 (da) | Smagsmaskeret faste sammensætninger af veterinærmedicin | |
| DK1828137T3 (da) | 4-Cycloalkyl-substituerede tetrahydroquinolinderivater og deres anvendelse som medikamenter | |
| DK1691804T3 (da) | Nitrooxydderivater af carvedilol og andre beta-blokkere som antihypertensive lægemidler | |
| DK1387838T3 (da) | Cyanoanthranylamid-derivater og deres anvendelse som lægemidler |